Arizona State Retirement System’s MoonLake Immunotherapeutics MLTX Stock Holding History

Arizona State Retirement System’s Portfolio MLTX Stock Details MLTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$233K	Buy	+11,968	New	+$217K	﹤0.01%	1906
2025 Q3	–	Sell	-6,428	Closed	-$303K	–	2109
2025 Q2	$303K	Buy	6,428 +96	+2%	+$3.91K	﹤0.01%	1730
2025 Q1	$247K	Sell	6,332 -39	-0.6%	-$1.68K	﹤0.01%	1790
2024 Q4	$345K	Buy	6,371 +35	+0.6%	+$1.79K	﹤0.01%	1678
2024 Q3	$319K	Buy	+6,336	New	+$297K	﹤0.01%	1728
2024 Q2	–	Sell	-4,942	Closed	-$248K	–	2136
2024 Q1	$248K	Sell	4,942 -59	-1%	-$3.2K	﹤0.01%	1817
2023 Q4	$302K	Sell	5,001 -146	-3%	-$7.53K	﹤0.01%	1715
2023 Q3	$293K	Buy	+5,147	New	+$284K	﹤0.01%	1676

Other funds holding MLTX

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Jupiter Topco New York $245B AUM

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Arizona State Retirement System's MLTX Position: Q2 2026 in Review

Arizona State Retirement System opened a new position in MoonLake Immunotherapeutics (MLTX) in Q2 2026: 11,968 shares worth $233K. The stake represents ﹤0.01% of the portfolio and ranks #1906 among its holdings. This is a return to the name: Arizona State Retirement System previously reported a position in MLTX as recently as Q2 2025.

Arizona State Retirement System first reported a position in MLTX in Q3 2023 and has held it in 8 quarters since. The position peaked at $345K in Q4 2024. 173 funds tracked by Wall St. Rank hold MLTX as of Q2 2026.

Arizona State Retirement System held 11,968 shares of MoonLake Immunotherapeutics worth $233K as of Q2 2026.
MoonLake Immunotherapeutics was a new Arizona State Retirement System position in Q2 2026.
MoonLake Immunotherapeutics made up ﹤0.01% of Arizona State Retirement System's portfolio in Q2 2026, its #1906 holding.
Arizona State Retirement System first reported a position in MoonLake Immunotherapeutics in Q3 2023 and has held it in 8 quarters since.
Arizona State Retirement System's MoonLake Immunotherapeutics position peaked at $345K in Q4 2024.
173 funds tracked by Wall St. Rank held MoonLake Immunotherapeutics as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.